PubMed

Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: prominent expression of P-cadherin.

Ben Hamida A, Labidi IS, Mrad K, Charafe-Jauffret E, Ben Arab S, Esterni B, Xerri L, Viens P, Bertucci F, Birnbaum D, Jacquemier J.

BMC Cancer. 2008 Jan 29;8:28.PMID: 18230143 [PubMed - indexed for MEDLINE]Related articlesFree article

Immunophenotypic analysis of inflammatory breast cancers: identification of an 'inflammatory signature'.

Charafe-Jauffret E, Tarpin C, Bardou VJ, Bertucci F, Ginestier C, Braud AC, Puig B, Geneix J, Hassoun J, Birnbaum D, Jacquemier J, Viens P.

J Pathol. 2004 Mar;202(3):265-73.PMID: 14991891 [PubMed - indexed for MEDLINE]Related articles

Persistent E-cadherin expression in inflammatory breast cancer.

Kleer CG, van Golen KL, Braun T, Merajver SD.

Mod Pathol. 2001 May;14(5):458-64.PMID: 11353057 [PubMed - indexed for MEDLINE]Related articlesFree article

Inflammatory breast cancers in Tunisia and France show similar immunophenotypes.

Charafe-Jauffret E, Mrad K, Intidhar Labidi S, Ben Hamida A, Ben Romdhane K, Ben Abdallah M, Ginestier C, Esterni B, Birnbaum D, Ben Ayed F, Xerri L, Viens P, Mezlini A, Jacquemier J.

Breast. 2007 Aug;16(4):352-8. Epub 2007 Mar 13.PMID: 17360185 [PubMed - indexed for MEDLINE]Related articles

P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ.

Paredes J, Lopes N, Milanezi F, Schmitt FC.

Virchows Arch. 2007 Jan;450(1):73-80. Epub 2006 Nov 23.PMID: 17123107 [PubMed - indexed for MEDLINE]Related articles

Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling.

Van Laere SJ, Van den Eynden GG, Van der Auwera I, Vandenberghe M, van Dam P, Van Marck EA, van Golen KL, Vermeulen PB, Dirix LY.

Breast Cancer Res Treat. 2006 Feb;95(3):243-55. Epub 2005 Oct 27.PMID: 16261404 [PubMed - indexed for MEDLINE]Related articles

p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas.

Matos I, Dufloth R, Alvarenga M, Zeferino LC, Schmitt F.

Virchows Arch. 2005 Oct;447(4):688-94. Epub 2005 Oct 19.PMID: 16012853 [PubMed - indexed for MEDLINE]Related articles

Microvessel density, expression of estrogen receptor alpha, MIB-1, p53, and c-erbB-2 in inflammatory breast cancer.

McCarthy NJ, Yang X, Linnoila IR, Merino MJ, Hewitt SM, Parr AL, Paik S, Steinberg SM, Hartmann DP, Mourali N, Levine PH, Swain SM.

Clin Cancer Res. 2002 Dec;8(12):3857-62.PMID: 12473600 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry.

Zell JA, Tsang WY, Taylor TH, Mehta RS, Anton-Culver H.

Breast Cancer Res. 2009;11(1):R9. Epub 2009 Feb 19.PMID: 19228416 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognostic markers in triple-negative breast cancer.

Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO.

Cancer. 2007 Jan 1;109(1):25-32.PMID: 17146782 [PubMed - indexed for MEDLINE]Related articlesFree article

P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation.

Paredes J, Albergaria A, Oliveira JT, Jerónimo C, Milanezi F, Schmitt FC.

Clin Cancer Res. 2005 Aug 15;11(16):5869-77.PMID: 16115928 [PubMed - indexed for MEDLINE]Related articlesFree article

Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.

González LO, Corte MD, Junquera S, González-Fernández R, del Casar JM, García C, Andicoechea A, Vázquez J, Pérez-Fernández R, Vizoso FJ.

Hum Pathol. 2009 Sep;40(9):1224-33. Epub 2009 May 12.PMID: 19439346 [PubMed - indexed for MEDLINE]Related articles

Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.

Rakha EA, Putti TC, Abd El-Rehim DM, Paish C, Green AR, Powe DG, Lee AH, Robertson JF, Ellis IO.

J Pathol. 2006 Mar;208(4):495-506.PMID: 16429394 [PubMed - indexed for MEDLINE]Related articles

Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer.

Arnes JB, Brunet JS, Stefansson I, Bégin LR, Wong N, Chappuis PO, Akslen LA, Foulkes WD.

Clin Cancer Res. 2005 Jun 1;11(11):4003-11.PMID: 15930334 [PubMed - indexed for MEDLINE]Related articlesFree article

Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study.

Van der Auwera I, Van den Eynden GG, Colpaert CG, Van Laere SJ, van Dam P, Van Marck EA, Dirix LY, Vermeulen PB.

Clin Cancer Res. 2005 Nov 1;11(21):7637-42.PMID: 16278382 [PubMed - indexed for MEDLINE]Related articlesFree article

Tissue microarrays for testing basal biomarkers in familial breast cancer cases.

Dufloth RM, Matos I, Schmitt F, Zeferino LC.

Sao Paulo Med J. 2007 Jul 5;125(4):226-30.PMID: 17992394 [PubMed - indexed for MEDLINE]Related articlesFree article

Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.

Van den Eynden GG, Van Laere SJ, Van der Auwera I, Merajver SD, Van Marck EA, van Dam P, Vermeulen PB, Dirix LY, van Golen KL.

Breast Cancer Res Treat. 2006 Feb;95(3):219-28. Epub 2005 Oct 22.PMID: 16244790 [PubMed - indexed for MEDLINE]Related articles

Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.

Hance KW, Anderson WF, Devesa SS, Young HA, Levine PH.

J Natl Cancer Inst. 2005 Jul 6;97(13):966-75.PMID: 15998949 [PubMed - indexed for MEDLINE]Related articlesFree article

Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.

Thorat MA, Marchio C, Morimiya A, Savage K, Nakshatri H, Reis-Filho JS, Badve S.

J Clin Pathol. 2008 Mar;61(3):327-32. Epub 2007 Nov 23.PMID: 18037662 [PubMed - indexed for MEDLINE]Related articles

The biological and prognostic significance of cell polarity and E-cadherin in grade I infiltrating ductal carcinoma of the breast.

Tan DS, Potts HW, Leong AC, Gillett CE, Skilton D, Harris WH, Liebmann RD, Hanby AM.

J Pathol. 1999 Sep;189(1):20-7.PMID: 10451483 [PubMed - indexed for MEDLINE]Related articles